<<

Guidance on minimising photosensitivity and phototoxicity reactions between and sunlight Version 3

Everyone should be protected from excess exposure to the sun by avoiding the sun at midday and covering up – to include wearing a hat and utilising appropriate . Some medicines can sensitise patients to greater reaction to sunlight. These patients should be even more cautious in avoiding direct exposure to the sun, and they should always use a high factor sunscreen.

How likely are photosensitising reactions to occur? The table below identifies drugs that are known to have the potential to cause photosensitising reactions. Some of them, (mostly newer ones), have been evaluated regarding the likelihood of occurrence. In these cases the following words have been used to specify how many patients are likely to be affected:  very common: more than 1 in 10  common: more than 1 in 100, but less then 1 in 10  uncommon: more than 1 in 1000, but less than 1 in 100  rare: more than 1 in 10000, but less than 1 in 1000  very rare: less than 1 in 10000

Please note, however, that these data mostly stem from voluntary reporting systems, which may be biased and inaccurate 1. This means that drugs for which no data exist cannot be assumed to be less likely to cause a reaction when the patient is exposed to sunlight. Where data are more reliable, drugs are required to carry a cautionary label: “Avoid exposure of skin to direct sunlight or sun lamps”.

Which drugs are involved? Major drug groups that can be expected to cause photosensitivity are: - based (, )2, sulfonamides, (such as doxycycline)2, and quinolone antibacterials. Some diuretics, amiodarone2 and some anti-inflammatory drugs have also been associated with these types of reaction1.

If you require this document in an alternative format, i.e. easy read, large text, audio, Braille or a community language please contact the pharmacy team on 01243 623349 (Text Relay calls welcome)

What is the worst that could happen? The following reactions can occur in response to drugs: phototoxicity, photoallergy, planus lichenoid reaction, , and subacute cutaneous lupus erythematosus3. Phototoxic reactions usually present as an exaggerated response minutes to hours after exposure to the sun, whereas photoallergic reactions manifest after 24 to 48 hours, usually as a pruritic eczematous eruption4. Mortality is rare and generally only occurs in individuals exposed to large doses of psoralens, (a specialist drug used to treat not listed in the table below), and large amounts of sunlight. Even so, drug-induced photosensitivity can cause significant morbidity in some individuals, who must severely limit their exposure to natural or artificial sunlight, (e.g. in persistent light reactivity after photoallergy).

It has also been suggested that prolonged exposure to photosensitising drugs has carcinogenic potential3. In most patients, however, the prognosis is excellent, once the offending agent has been removed, although complete resolution of the photosensitivity may take several weeks, or even several months with some compounds.

2

DRUG CLASS GROUP DRUGS FREQUENCY- IF REPORTED ACE inhibitors5 Losartan6 Not known 6 Valsartan6 Reports2 and ARBs 6 Lisinopril As symptom complex 2 6 Quinapril Reports Not known 5 6 Captopril Very rare Fosinopril6 Reports1

Enalapril6 One case report2; part of complex

syndrome6 Perindopril6 Uncommon6 Ramipril6 One case report2; very rare6 Antibiotics Quinolones2,5 Moxifloxacin6 Reports6 Ciprofloxacin6 Rare6 6 Reports Nalidixic acid BNF cautionary label- Rare Ofloxacin5 Very Rare, BNF cautionary label 5,6 Sulphonamides Co-trimoxazole Very rare Tetracyclines5 Azithromycin6 Uncommon6 6 Lymecycline Not known Oxytetracycline6 Rare Demeclocycline BNF cautionary label- Common Doxycycline Common, BNF cautionary label 6 Minocycline Rare. Reports Reports; unknown6 6 Others Tigecycline Reports Gentamicin Reports1 2 Reports Nitrofurantoin Reports Trimethoprim5,6 Rare6 Amitriptyline6 Frequency not known5 2,6 6 Frequency not known Doxepin6 Not known5 Imipramine2,6 Reports6 Frequency not known5 Lofepramine6 Reports Nortriptyline5,6 Rare Others St John’s Wort Reports ? Venlafaxine2,5,6 Uncommon 2 Reports SSRIs2,5 Uncommon6 2 Unclear Duloxetine6 Rare Rare6 Rare6 Very rare6

Sertraline Frequency not known, reports6 Antidiabetics Sulfonylureas6 Glimepiride6 Not known6 2 (oral) Reports Gliclazide6 Not known Glipizide6 Not known6 Antiepileptics Carbamazepine2 Very rare5,6 Phenobarbital6 Reports 2,5,6 6 Reports, Not known

Ketoconazole 6 Not known Terbinafine Very rare5,6 Voriconazole2 Reports6 BNF Cautionary Label- Uncommon

3

6 Antihistamines5 Alimemazine 6 Cyproheptadine6 Cyclizine6 Reports Desloratadine6 Not known (2) 6 -Rare Cetirizine6 Not known6 Antimalarials Malarone Unknown6 Chloroquine and 6 hydroxychloroquine Rare5 Pyrimethamine reports 1,2 Quinine5,6 Antineoplastics Azathioprine6 Reports 1 Rare6 Uncommon6 Dasatinib Uncommon6 Doxorubicin6 Reports2 Uncommon6 Hydroxyurea 6 SPC warning to avoid sun exposure () Potential Risk6 Imatinib5 Common5 Lenalidomide Uncommon6 Paclitaxel6 Uncommon6 Pazopanib Uncommon6 Common6 Reports6 Fluorouracil6 Reports2Uncommon6 Methotrexate5,6 Uncommon Not known6 Vemurafenib Very Common6 One case report2 Antipsychotics5 Sulpiride6 Reports6 6 Butyrophenones Reports 1 rare5 Uncommon6 Phenothiazines2 Chlorpromazine5,6 BNF cautionary label, Not known6 Fluphenazine6 Pericyazine6 Pipotiazine6 Reports Prochlorperazine1,6 Promethazine1 Trifluoperazine6 Reports Flupentixol2,6 Reports Zuclopenthixol6 Atypical Aripiprazole6 Frequency not known6 2 5,6 antipsychotics Uncommon Clozapine2 Reports Not known6 Reports2 Diuretics Acetazolamide Reports 1 rare5,6 Reports 1 Bendroflumethiazide5,6 Uncommon, Reports6 Bumetanide5 Reports Hydrochlorothiazide5 uncommon Indapamide2,5,6 Not known Furosemide2,5,6 Uncommon Spironolactone6 Reports 16 Triamterene2 Reports 1,2 rare5

4

NSAIDs5 Indometacin6 Reports6 Celecoxib2,6 Rare Very Rare6 Diclofenac5,6 BNF cautionary label, Very Rare6 Reports6 Ibuprofen2,6 Reports Ketoprofen6 Reports , Not known6 Mefenamic acid6 Reports1 Naproxen2,6 Rare Piroxicam2,6 Infrequent Retinoids2,5 Isotretinoin6 Very rare6, BNF cautionary label Acitretin BNF cautionary label, Uncommon6 BNF cautionary label Adapalene Other drugs Aciclovir Common6 6 Very Rare 6 Very Rare Alendronate6 Rare Amiodarone2,5 Very common, BNF cautionary label Rare6 Atorvastatin2 Reports 6 6 Very rare hydrochloride Benzoyl peroxide and 6 Common gel Bezafibrate6 Uncommon Bicalutamide6 Rare Botulinum toxin type A Uncommon6 Calcipotriol6 Reports Certolizumab Uncommon6 Ciprofibrate Very rare6 Clopidogrel(2) Reports Coal tar5 Reports Cobimetinib 6 Common hemifumarate Corticosteroids Reports 1 Uncommon6 Dapsone2 One report Diltiazem2,5 Uncommon; not known6 Reports 1 Uncommon6 Eltrombopag Reports6 Esomeprazole Rare6 Etodolac6 Very Rare Reports6 Fenofibrate Uncommon6 Not known6 Fosaprepitant Rare6 Reports 1 Interferon alfa-2b Common6 Reports6 Leflunomide2 Reports Levothyroxine6 Reports6 Unknown6 Uncommon6 Mesalazine2 Reports Metoprolol6 Very rare Uncommon6 Reports6 2,5 and other 1 5 Reports - rare CCBs, including

5

amlodipine6 and felodipine6 Human normal 6 Reports immunoglobulin Oral contraceptives (oestrogens and Reports progestagens)2 Omalizumab Uncommon6 Oxerutins Very Rare6 Oxybutinin6 Reports, Not known6 Oxycodone6 Common Para-amino-benzoic Reports acid (preservative) Pantoprazole Not known6 Peginterferon alfa-2a Common6 Very Common6 Pimecrolimus topical BNF cautionary label Pitolisant Rare6 Pravastatin2 Reports Pyrazinamide Reports6 Proton pump inhibitors6 , Rare lansoprazole Ranitidine2 Reports Ribavirin Common6 Romiplostim Uncommon6 Uncommon6 Reports 1 Rare6 Common6 Sodium BNF cautionary label (irreversible aurothiomalate pigmentation in sun-exposed areas) Sulfasalazine Reports 1 – Frequency not known5,6 BNF cautionary label; uncommon6 Tazarotene Not known6 Uncommon6 Not known6 Reports6 Tipranavir Reports6 Very Rare6 Torasemide Very Rare6 Trandolapril Rare6 Valaciclovir Common6 Vardenafil6 Rare Common6 Zaleplon5 Uncommon 5- Uncommon6

With groups of drugs please assume that all members cause photosensitivity unless stated otherwise.

Please note that this list is not exhaustive. Consult your local pharmacy team or Medicines Information department for specific information

References: 1. Moore DE. Drug-Induced Cutaneous Photosensitivity. Drug Safety 2002; 25 (5): p. 345- 372. Available from http://www.ncbi.nlm.nih.gov/pubmed/12020173?dopt=Abstract (accessed 18 march 2013) 2. Drucker AM, Rosen CF. Drug-Induced Photosensitivity. Drug Safety 2011; 34(10):821-837. First accessed 21st August 2013. Accessed to review guideline: 20/11/16

6

3. Zhang, A., Y., Craig, A., E. 2007. Drug-Induced Hypersensitivity. [Online] (Updated 19 March 2007) Available at: http://emedicine.medscape.com/article/1049648-print [accessed 29 April 2009] 4. MedicinesComplete © Pharmaceutical Press. 2013. Martindale: The Complete Drug Reference. [Online] Drug-induced photosensitivity (Latest modification 4-Feb-2008) Available at: http://www.medicinescomplete.com [Accessed 20/11/16]. 5. BNF. Online edition. Individual monographs. 6. Datapharm Communications Ltd. 2013. electronic Medicines Compendium. [Online] Available at: http://emc.medicines.org.uk Individual monographs. [Accessed 20/11/16].

Original authors: Josef Elias – Clinical Pharmacist Gus Fernandez – Clinical Pharmacist

Reviewed November 2016 by: Ellie Morton- Rotational Pharmacist Paulina Sajdak Orzechowska- Clinical Pharmacist

Supported by: Reviewed by the Medicine Information Department Western Sussex Hospitals NHS Foundation Trust November 2016

Version 1 issued: March 2010

Version 2 issued: October 2013

Version 3 issued: November 2016

Date of next review: November 2020

7